1. Home
  2. MSGM vs CLRB Comparison

MSGM vs CLRB Comparison

Compare MSGM & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorsport Games Inc.

MSGM

Motorsport Games Inc.

HOLD

Current Price

$4.30

Market Cap

13.4M

Sector

Technology

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.36

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGM
CLRB
Founded
2018
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.0M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
MSGM
CLRB
Price
$4.30
$2.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
47.2K
175.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
252.13
N/A
EPS
0.06
N/A
Revenue
$741,000.00
N/A
Revenue This Year
$69.73
N/A
Revenue Next Year
$146.81
N/A
P/E Ratio
$72.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.11
$0.29
52 Week High
$5.78
$10.19

Technical Indicators

Market Signals
Indicator
MSGM
CLRB
Relative Strength Index (RSI) 47.36 36.29
Support Level $3.95 N/A
Resistance Level $4.57 $3.40
Average True Range (ATR) 0.22 0.19
MACD -0.01 -0.07
Stochastic Oscillator 63.64 14.95

Price Performance

Historical Comparison
MSGM
CLRB

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: